ROC1 tumors failed to respond to treatment with antibodies against PD-1 and TIGIT (Fig. 3b, c), confirming that ROC1 is a cold tumor lacking immune cell infiltration and immune checkpoint expression (Fig. 2 and Supplementary Fig. 4) and thus a good model of ICI-resistant disease. Here, PDCD1 is linked to neoplasm.